Hille Koppen

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

Tony W. Ho, Michel D. Ferrari, David W. Dodick et al. · The Lancet · 2008 · 524 citations

Cluster Headache, Medicine, Pharmacotherapy +6

Structural Brain Changes in Migraine

Inge H. Palm‐Meinders, Hille Koppen, Gisela M. Terwindt et al. · JAMA · 2012 · 239 citations · Full text

Migraine and vascular disease biomarkers: A population-based case-control study

Gretchen E. Tietjen, Jagdish Khubchandani, Nabeel Herial et al. · Cephalalgia · 2017 · 60 citations · Full text

Vascular Disease, Migraine-stroke Association Remain, Cerebrovascular Disease +21

Volumetric brain changes in migraineurs from the general population

Inge H. Palm‐Meinders, Enrico B Arkink, Hille Koppen et al. · Neurology · 2017 · 54 citations

Severe unilateral headache caused by skull bone infarction with epidural haematoma in a patient with sickle cell disease

Samuel Arends, Jan Coebergh, Jean‐Louis Kerkhoffs et al. · Cephalalgia · 2011 · 45 citations